Pre-diagnosis dietary patterns and risk of multiple myeloma in the NIH-AARP diet and health study-Reference-Cited by-同舟云学术

Pre-diagnosis dietary patterns and risk of multiple myeloma in the NIH-AARP diet and health study

Published:2023-12-29 Issue: Volume: Page:
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Castro Francesca^ORCID,Parikh Richa^ORCID,Eustaquio Jelyn C.^ORCID,Derkach Andriy,Joseph Janine M.^ORCID,Lesokhin Alexander M.^ORCID,Usmani Saad Z.^ORCID,Shah Urvi A.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

https://www.nature.com/articles/s41375-023-02132-3.pdf

Reference19 articles.

1. Huang J, Chan SC, Lok V, Zhang L, Lucero-Prisno DE 3rd, Xu W, et al. The epidemiological landscape of multiple myeloma: a global cancer registry estimate of disease burden, risk factors, and temporal trends. Lancet Haematol. 2022;9:e670–7.

2. Malik MA, Sweeney NW, Jafri M, Derkach A, Chmielewski C, Adintori PA, et al. Nutrition perceptions, needs and practices among patients with plasma cell disorders. Blood Cancer J. 2022;12:70.

3. Key TJ, Appleby PN, Crowe FL, Bradbury KE, Schmidt JA, Travis RC. Cancer in British vegetarians: updated analyses of 4998 incident cancers in a cohort of 32,491 meat eaters, 8612 fish eaters, 18,298 vegetarians, and 2246 vegans. Am J Clin Nutr. 2014;100:378s–85s.

4. Lee DH, Fung TT, Tabung FK, Colditz GA, Ghobrial IM, Rosner BA, et al. Dietary pattern and risk of multiple myeloma in two large prospective US Cohort Studies. JNCI cancer Spectr. 2019;3:pkz025.

5. Tabung FK, Smith-Warner SA, Chavarro JE, Wu K, Fuchs CS, Hu FB, et al. Development and validation of an empirical dietary inflammatory index. J Nutr. 2016;146:1560–70.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vegan, Pescatarian, Vegetarian Diet and Cancer Risk;Bilecik Şeyh Edebali Üniversitesi Sağlık Bilimleri Fakültesi Dergisi;2024-01-25

2. A High-Fiber Dietary Intervention (NUTRIVENTION) in Precursor Plasma Cell Disorders Improves Disease Biomarkers and Delays Progression to Myeloma;2024